Healthcare & Medical Investment Corporation (TYO:3455)
Japan
· Delayed Price · Currency is JPY 107,000
-1,500 (-1.38%)
Mar 4, 2025, 9:00 AM JST
TYO:3455 Income Statement
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | FY 2024 | FY 2024 | FY 2023 | FY 2023 | FY 2023 | 2022 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jul '23 Jul 31, 2023 | Jan '23 Jan 31, 2023 | 2022 - 2018 |
| Rental Revenue | 4,952 | 4,877 | 4,799 | 4,866 | 4,799 | Upgrade
|
| Gain (Loss) on Sale of Assets (Rev) | - | - | 204.65 | 204.65 | 204.65 | Upgrade
|
| Other Revenue | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Revenue | 4,952 | 4,877 | 5,003 | 5,070 | 5,003 | Upgrade
|
| Revenue Growth (YoY | 1.55% | -2.53% | -1.32% | 1.34% | 5.51% | Upgrade
|
| Property Expenses | 2,195 | 2,193 | 2,106 | 2,138 | 2,106 | Upgrade
|
| Selling, General & Administrative | 46.62 | 44.67 | 57.6 | 52.39 | 57.6 | Upgrade
|
| Other Operating Expenses | 157.68 | 117.14 | 120.32 | 157.94 | 120.32 | Upgrade
|
| Total Operating Expenses | 2,399 | 2,354 | 2,284 | 2,348 | 2,284 | Upgrade
|
| Operating Income | 2,553 | 2,523 | 2,719 | 2,722 | 2,719 | Upgrade
|
| Interest Expense | -375.96 | -277.71 | -213.07 | -304.24 | -213.07 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.15 | 0.09 | 0.09 | 0.09 | Upgrade
|
| Other Non-Operating Income | -68.01 | -128.13 | -128.15 | -65.9 | -128.15 | Upgrade
|
| EBT Excluding Unusual Items | 2,109 | 2,117 | 2,378 | 2,352 | 2,378 | Upgrade
|
| Total Insurance Settlements | - | 2.34 | 1.82 | 0.25 | 1.82 | Upgrade
|
| Other Unusual Items | -5 | - | - | -5 | - | Upgrade
|
| Pretax Income | 2,104 | 2,119 | 2,380 | 2,347 | 2,380 | Upgrade
|
| Income Tax Expense | 0.9 | 1.76 | 1.63 | 0.71 | 1.63 | Upgrade
|
| Net Income | 2,103 | 2,117 | 2,379 | 2,346 | 2,379 | Upgrade
|
| Net Income to Common | 2,103 | 2,117 | 2,379 | 2,346 | 2,379 | Upgrade
|
| Net Income Growth | -0.66% | -10.98% | 1.37% | -1.35% | 8.11% | Upgrade
|
| Basic Shares Outstanding | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Diluted Shares Outstanding | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | 0.05% | -0.05% | 0.05% | 0.05% | Upgrade
|
| EPS (Basic) | 5850.94 | 5889.94 | 6619.45 | 6526.77 | 6619.45 | Upgrade
|
| EPS (Diluted) | 5850.94 | 5889.94 | 6619.45 | 6526.77 | 6619.45 | Upgrade
|
| EPS Growth | -0.66% | -11.02% | 1.42% | -1.40% | 8.06% | Upgrade
|
| Dividend Per Share | - | 6517.000 | 6924.000 | - | 6924.000 | Upgrade
|
| Dividend Growth | - | -5.88% | - | - | - | Upgrade
|
| Operating Margin | 51.55% | 51.72% | 54.35% | 53.68% | 54.35% | Upgrade
|
| Profit Margin | 42.47% | 43.42% | 47.54% | 46.28% | 47.54% | Upgrade
|
| Free Cash Flow Margin | 70.47% | 67.40% | 99.88% | 94.06% | 99.88% | Upgrade
|
| EBITDA | 3,715 | 3,649 | 3,835 | 3,853 | 3,835 | Upgrade
|
| EBITDA Margin | 75.01% | 74.83% | 76.65% | 75.99% | 76.65% | Upgrade
|
| D&A For Ebitda | 1,162 | 1,127 | 1,116 | 1,131 | 1,116 | Upgrade
|
| EBIT | 2,553 | 2,523 | 2,719 | 2,722 | 2,719 | Upgrade
|
| EBIT Margin | 51.55% | 51.72% | 54.35% | 53.68% | 54.35% | Upgrade
|
| Funds From Operations (FFO) | 1,615 | 3,243 | 3,289 | 1,637 | 3,289 | Upgrade
|
| Adjusted Funds From Operations (AFFO) | - | 3,243 | 3,289 | - | 3,289 | Upgrade
|
| FFO Payout Ratio | 73.02% | 75.77% | 67.42% | 73.88% | 67.42% | Upgrade
|
| Effective Tax Rate | 0.04% | 0.08% | 0.07% | 0.03% | 0.07% | Upgrade
|
| Revenue as Reported | 2,438 | 4,877 | 5,003 | 2,632 | 5,003 | Upgrade
|
Source: S&P Capital IQ. Real Estate template. Financial Sources.